Edgestream Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.26M | Buy |
+37,754
| New | +$8.26M | 0.23% | 130 |
|
|
2023
Q3 | – | Sell |
-4,706
| Closed | -$1.8M | – | 1000 |
|
|
2023
Q2 | $1.8M | Buy |
4,706
+836
| +22% | +$320K | 0.16% | 208 |
|
|
2023
Q1 | $1.34M | Buy |
+3,870
| New | +$1.34M | 0.15% | 224 |
|
|
2022
Q1 | – | Sell |
-3,504
| Closed | -$1.64M | – | 652 |
|
|
2021
Q4 | $1.64M | Sell |
3,504
-5,386
| -61% | -$2.53M | 0.1% | 257 |
|
|
2021
Q3 | $3.77M | Sell |
8,890
-2,757
| -24% | -$1.17M | 0.23% | 150 |
|
|
2021
Q2 | $4.18M | Sell |
11,647
-5,246
| -31% | -$1.88M | 0.25% | 145 |
|
|
2021
Q1 | $4.76M | Buy |
16,893
+2,678
| +19% | +$755K | 0.27% | 146 |
|
|
2020
Q4 | $4.03M | Buy |
+14,215
| New | +$4.03M | 0.2% | 155 |
|